Correlation Between Verve Therapeutics and Finch Therapeutics

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Finch Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Finch Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Finch Therapeutics Group, you can compare the effects of market volatilities on Verve Therapeutics and Finch Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Finch Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Finch Therapeutics.

Diversification Opportunities for Verve Therapeutics and Finch Therapeutics

0.01

Correlation Coefficient

Verve Therapeutics  Finch Therapeutics

Significant diversification

The 3 months correlation between Verve and Finch is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Finch Therapeutics Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Finch Therapeutics and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Finch Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Finch Therapeutics has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Finch Therapeutics go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Finch Therapeutics

Given the investment horizon of 90 days Verve Therapeutics is expected to under-perform the Finch Therapeutics. In addition to that, Verve Therapeutics is 2.39 times more volatile than Finch Therapeutics Group. It trades about -0.02 of its total potential returns per unit of risk. Finch Therapeutics Group is currently generating about 0.01 per unit of volatility. If you would invest  853.00  in Finch Therapeutics Group on October 22, 2024 and sell it today you would lose (2.00) from holding Finch Therapeutics Group or give up 0.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	4.35%
Values	Daily Returns

Verve Therapeutics  vs.  Finch Therapeutics Group

Verve Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Verve Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Verve Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Finch Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Finch Therapeutics Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Finch Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Verve Therapeutics and Finch Therapeutics

The main advantage of trading using opposite Verve Therapeutics and Finch Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Finch Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Finch Therapeutics will offset losses from the drop in Finch Therapeutics' long position.

The idea behind Verve Therapeutics and Finch Therapeutics Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.